The FDA has even approved a drug built with cannabidiol for that intent (Epidiolex). Even so the agency only recommends it for two uncommon sorts of childhood epilepsy referred to as Lennox-Gastaut syndrome and Dravet syndrome.Offered these linked genetic and environmental vulnerabilities, added details from prospective, longitudinal study (reports